CD8A and neoplasm: We used a murine syngeneic tumor model, where the implanted tumor cells express ovalbumin (OVA) as a surrogate tumor antigen which can be specifically recognized by MHC class I-restricted, OVA-specific CD8+ T cells (OT-I cells).